企業プロフィール
Ventyx Biosciences, Inc. 株価・ニュース・カタリスト
- ティッカー:
- VTYX
- 取引所:
- NASDAQ
- セクター:
- Small Molecule Drugs
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for VTYX.
企業概要
事業概要
Ventyx Biosciences is an immunology company building small-molecule therapies for inflammatory and autoimmune diseases.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Ventyx sits in early-stage biopharmaceuticals.
ビジネスモデルの特徴
The company relies on clinical proof-of-concept, dose selection, and the chance to build a differentiated inflammation pipeline.
バイオ業界での位置付け
Ventyx is a catalyst-driven immunology name whose valuation depends heavily on clinical data quality.
今後のカタリスト
- Ventyx's catalysts are its inflammation programs, especially the NLRP3 and related assets that still need human proof. The stock remains highly data-sensitive because the platform is still early.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。